News

Lonza appoints Christian Seufert as President of the CHI Division and member of the Executive Committee Christian brings a unique level of experience and expertise from a...
New hard gelatin capsule provides a bright white color, while meeting titanium dioxide-free requirements for foods in the European Union The new capsule features an...
Lonza meets pressing market need by launching first ever coating-free capsule to support intestinal delivery of acid-sensitive APIs Innovative Capsugel® Enprotect™ capsule can...
Lonza signs agreement to divest its Capsules & Health Ingredients (CHI) business to Lone Star Funds, for an enterprise value of CHF 2.3 billion (USD 3 billion) at closing. The...
Lonza launches Capsugel® Enprotect® size 9 capsule to support the evaluation of candidate drugs New size 9 capsule enables pre-clinical testing in rodents, which accelerates...
The new facility will serve as a Center of Excellence for co-innovation with pharmaceutical customers on formulation and encapsulation innovation projects The facility includes...
Tailored offering for companies developing smart capsules includes bespoke targeted drug delivery solutions and customized capsule designs for oral biologic drugs Service...
New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to...
As part of Lonza Capsules & Health Ingredients’ (CHI) continued focus on sustainability, a new Center of  Applied Sustainability has been established to accelerate...
New organic pullulan immediate release capsule is the first USDA organic certified capsule to be manufactured in North America, positioning brands...